by Kristin Rowan | Jan 9, 2025 | M&A, Regulatory
by Kristin Rowan, Editor UHG and Amedisys Waive Termination The UnitedHealth Group and Amedisys merger has been an ongoing story since the initial merger agreement was signed in June of 2023. The proposed merger came under scrutiny by the Federal Trade Commission...
by Kristin Rowan | Nov 15, 2024 | CMS, M&A, Medicare Advantage, Regulatory
by Kristin Rowan, Editor Justice Department Sues In September of 2023, UnitedHealth Group made a bid to purchase Amedysis. That acquisition has been under scrutiny since last year. When the bid was announced, the Department of Justice began an inquiry, asking for...
by Kristin Rowan | Aug 23, 2024 | Regulatory
by Kristin Rowan, Editor False Claims Act Violations According to allegations in U.S. es rel. Jones v Intrepid U.S.A. Healthcare Inc. and U.S. es rel. Rigney v Intrepid U.S.A. Inc., Intrepid U.S.A. Inc. (Intrepid) violated the False Claims Act multiple times over five...
by Rowan Report | Jul 19, 2024 | Partner News
FOR IMMEDIATE RELEASE Office of Public Affairs July 1, 2024 — Guardian Health Care Inc., Gem City Home Care LLC and Care Connection of Cincinnati LLC, home health agencies operating in Texas, Ohio and Indiana, along with their owner Evolution Health LLC...
by Elizabeth E. Hogue, Esq. | Mar 13, 2024 | Regulatory
by Elizabeth E. Hogue, Esq., DOJ Says “Knock on Our Door Before We Knock on Yours” On March 7, 2024, the U.S. Department of Justice (DOJ) announced a new pilot program that includes financial incentives for whistleblowers to report violations. The new...
